Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > US Delisted and moved to the pink sheet trading platform !

<< Previous

Bullboard Posts

Next >>

Comment by Edcandoon Feb 14, 2023 7:22pm

152 Views

Post# 35286375

RE:RE:US Delisted and moved to the pink sheet trading platform !

Well the biggest reason a company will move down to pinks is because it's free to list (or very little) while being on QB tier costs at least $15,000 USD/year. I didn't really follow much anymore but I'd imagine there was very little to no volume on OTCQB to justify the expense for a pre revenue bio company . To the poster who said it's so Guy can move money around lol. While yes there is less disclosure needed on pinks Vs QB, they still have all the same disclosure rules and fraud laws in Canada /Canadian listing. So funny, there's enough real reasons to bash a company there's no reason to just make stuff up

<< Previous

Bullboard Posts

Next >>

Pro Women’s Hockey League comes to NHL 25 in December